A detailed history of Choreo, LLC transactions in Amgen Inc stock. As of the latest transaction made, Choreo, LLC holds 16,064 shares of AMGN stock, worth $5.08 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
16,064
Previous 3,985 303.11%
Holding current value
$5.08 Million
Previous $1.13 Million 342.98%
% of portfolio
0.08%
Previous 0.03%

Shares

41 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$262.75 - $319.31 $3.17 Million - $3.86 Million
12,079 Added 303.11%
16,064 $5.02 Million
Q1 2024

May 02, 2024

BUY
$268.87 - $324.56 $36,028 - $43,491
134 Added 3.48%
3,985 $1.13 Million
Q4 2023

Feb 05, 2024

BUY
$255.7 - $288.46 $46,026 - $51,922
180 Added 4.9%
3,851 $1.11 Million
Q3 2023

Nov 08, 2023

BUY
$218.65 - $271.46 $17,492 - $21,716
80 Added 2.23%
3,671 $986,000
Q2 2023

Aug 04, 2023

BUY
$214.27 - $253.37 $5,999 - $7,094
28 Added 0.79%
3,591 $797,000
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $63,221 - $77,056
280 Added 8.53%
3,563 $861,000
Q4 2022

Feb 13, 2023

BUY
$229.03 - $291.01 $916 - $1,164
4 Added 0.12%
3,283 $862,000
Q3 2022

Oct 21, 2022

SELL
$224.46 - $253.15 $897 - $1,012
-4 Reduced 0.12%
3,279 $739,000
Q2 2022

Aug 11, 2022

BUY
$230.71 - $256.74 $14,304 - $15,917
62 Added 1.92%
3,283 $799,000
Q4 2021

Feb 08, 2022

SELL
$198.88 - $227.6 $34,207 - $39,147
-172 Reduced 5.07%
3,221 $725,000
Q3 2021

Nov 08, 2021

BUY
$212.27 - $248.7 $13,373 - $15,668
63 Added 1.89%
3,393 $721,000
Q2 2021

Aug 13, 2021

BUY
$233.58 - $259.14 $459,919 - $510,246
1,969 Added 144.67%
3,330 $812,000
Q1 2021

Apr 29, 2021

BUY
$221.91 - $258.6 $4,438 - $5,172
20 Added 1.49%
1,361 $339,000
Q4 2020

Feb 04, 2021

SELL
$216.38 - $257.67 $66,645 - $79,362
-308 Reduced 18.68%
1,341 $308,000
Q3 2020

Nov 03, 2020

BUY
$234.65 - $260.95 $146,656 - $163,093
625 Added 61.04%
1,649 $419,000
Q2 2020

Aug 14, 2020

SELL
$197.81 - $242.74 $22,945 - $28,157
-116 Reduced 10.18%
1,024 $242,000
Q1 2020

May 15, 2020

SELL
$182.24 - $241.7 $53,396 - $70,818
-293 Reduced 20.45%
1,140 $231,000
Q4 2019

Jun 04, 2020

SELL
$189.21 - $243.2 $12,109 - $15,564
-64 Reduced 4.28%
1,433 $346,000
Q3 2019

Jun 04, 2020

SELL
$174.11 - $208.62 $184,730 - $221,345
-1,061 Reduced 41.48%
1,497 $290,000
Q2 2019

Jun 04, 2020

SELL
$166.7 - $195.41 $33,340 - $39,082
-200 Reduced 7.25%
2,558 $471,000
Q1 2019

Jun 04, 2020

BUY
$180.87 - $203.88 $128,960 - $145,366
713 Added 34.87%
2,758 $524,000
Q4 2018

Jun 04, 2020

BUY
$178.4 - $208.25 $24,262 - $28,322
136 Added 7.12%
2,045 $398,000
Q3 2018

Jun 04, 2020

SELL
$185.29 - $208.89 $365,206 - $411,722
-1,971 Reduced 50.8%
1,909 $396,000
Q2 2018

Jun 04, 2020

SELL
$166.05 - $186.51 $69,408 - $77,961
-418 Reduced 9.73%
3,880 $716,000
Q1 2018

Jun 04, 2020

SELL
$169.43 - $198.0 $50,320 - $58,806
-297 Reduced 6.46%
4,298 $733,000
Q4 2017

Jun 04, 2020

BUY
$168.79 - $188.59 $247,277 - $276,284
1,465 Added 46.81%
4,595 $799,000
Q3 2017

Jun 04, 2020

BUY
$167.29 - $191.0 $101,879 - $116,319
609 Added 24.16%
3,130 $584,000
Q2 2017

Jun 04, 2020

SELL
N/A
-707 Reduced 21.9%
2,521 $434,000
Q1 2017

Jun 04, 2020

SELL
N/A
-40 Reduced 1.22%
3,228 $530,000
Q4 2016

Jun 04, 2020

BUY
N/A
13 Added 0.4%
3,268 $478,000
Q3 2016

Jun 04, 2020

BUY
N/A
491 Added 17.76%
3,255 $543,000
Q2 2016

Jun 04, 2020

BUY
N/A
600 Added 27.73%
2,764 $421,000
Q1 2016

Jun 04, 2020

BUY
N/A
363 Added 20.16%
2,164 $325,000
Q4 2015

Jun 04, 2020

SELL
N/A
-116 Reduced 6.05%
1,801 $292,000
Q3 2015

Jun 04, 2020

BUY
N/A
253 Added 15.2%
1,917 $265,000
Q2 2015

Jun 04, 2020

BUY
N/A
201 Added 13.74%
1,664 $255,000
Q1 2015

Jun 04, 2020

BUY
N/A
38 Added 2.67%
1,463 $234,000
Q4 2014

Jun 04, 2020

SELL
N/A
-125 Reduced 8.06%
1,425 $227,000
Q3 2014

Jun 04, 2020

BUY
N/A
1,550 New
1,550 $218,000
Q2 2014

Jun 04, 2020

SELL
N/A
-2,022 Closed
0 $0
Q1 2014

Jun 04, 2020

BUY
N/A
2,022
2,022 $249,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Choreo, LLC Portfolio

Follow Choreo, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Choreo, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Choreo, LLC with notifications on news.